Press releases

Month Year

Email alerts

May 21, 2014

Covidien Releases Two-Year Study Results Demonstrating Sustained Effectiveness of Drug-Coated Angioplasty Balloon Technology

ILLUMENATE First-in-Human Clinical Trial Supports the Stellarex™ Balloon with EnduraCoat™ Technology in Treating Peripheral Arterial Disease

PARIS--(BUSINESS WIRE)--May 22, 2014-- Covidien’s Stellarex™ drug-coated angioplasty balloon (Stellarex DCB) continues to be shown as safe and effective for treatment of peripheral arterial...
May 20, 2014

Medtronic Settles Global Patent Litigation with Edwards Lifesciences

TAVI and Surgical Patent Cases Resolved

MINNEAPOLIS - May 20, 2014 - Medtronic, Inc. (NYSE: MDT) announced that it has reached a global patent settlement agreement with Edwards Lifesciences Corporation (NYSE:EW). Under the terms of the...
May 20, 2014

Medtronic Reports Fourth Quarter and Fiscal Year 2014 Earnings

Q4 Revenue of $4.6 Billion Grew 3% at Constant Currency; 2% as Reported

MINNEAPOLIS - May 20, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2014, which ended April 25, 2014. The company reported worldwide...
May 20, 2014

Medtronic Announces CE Mark and Launch of NC Euphora(TM) Coronary Balloon

Noncompliant Balloon Provides Superior Deliverability and Controlled Growth for Challenging Coronary Angioplasty Procedures

MINNEAPOLIS -- May 20, 2014 -- Continuing its commitment to bringing advanced and clinically relevant interventional technologies to market, Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité
May 19, 2014

Medtronic Applauds AACE/ACE on Their Updated Insulin Pump Therapy Consensus Statement

MINNEAPOLIS - May 19, 2014 - Medtronic, Inc. (NYSE:MDT) applauds the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) on their updated...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa